TYPHIM VI INJECTION 0.025 mg/0.5 ml

4.1 Therapeutic indications

Prevention of typhoid fever in adults and in children over 2 years of age, and especially: travellers to endemic areas, migrants, health care professionals and military personnel.

4.3 Contraindications

Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 to formaldehyde or to casein (which may be present as traces in each dose, owing to their use during the manufacturing process) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

Vaccination should be postponed in case of acute febrile disease.

4.2 Posology and method of administration

Posology

RESTRICTED TO ADULTS AND CHILDREN OVER 2 YEARS OF AGE.

A single injection of 0.5 ml. If exposure to risk continues and depending on the level of exposure, revaccination will be performed every 2–3 years.

Paediatric population

The vaccination schedule is the same for children and for adults.

Method of administration

Intramuscular or subcutaneous route